Abstract:Importance Unlike medications, procedural interventions are rarely trialed against placebo prior to becoming accepted in clinical practice. When placebo-controlled trials are eventually conducted, procedural interventions may be less effective than previously believed. Objective To investigate the importance of including a placebo arm in trials of surgical and interventional procedures by comparing effect sizes from trials of the same procedure that do and do not include a placebo arm. Data Sources Searches of MEDLINE and Embase identified all placebo-controlled trials for procedural interventions in any specialty of medicine and surgery from inception to March 31, 2019. A secondary search identified randomized clinical trials assessing the same intervention, condition, and end point but without a placebo arm for paired comparison. Study Selection Placebo-controlled trials of anatomically site-specific procedures requiring skin incision or endoscopic techniques were eligible for inclusion; these were then matched to trials without placebo control that fell within prespecified limits of heterogeneity. Data Extraction and Synthesis Random-effects meta-regression, with placebo and blinding as a fixed effect and intervention and end point grouping as random effects, was used to calculate the impact of placebo control for each end point. Data were analyzed from March 2019 to March 2020. Main Outcomes and Measures End points were examined in prespecified subgroups: patient-reported or health care professional–assessed outcomes, quality of life, pain, blood pressure, exercise-related outcomes, recurrent bleeding, and all-cause mortality. Results Ninety-seven end points were matched from 72 blinded, placebo-controlled trials (hereafter, blinded) and 55 unblinded trials without placebo control (hereafter, unblinded), including 111 500 individual patient end points. Unblinded trials had larger standardized effect sizes than blinded trials for exercise-related outcomes (standardized mean difference [SMD], 0.59; 95% CI, 0.29 to 0.89; P &lt; .001) and quality-of-life (SMD, 0.32; 95% CI, 0.11 to 0.53; P = .003) and health care professional–assessed end points (SMD, 0.40; 95% CI, 0.18 to 0.61; P &lt; .001). The placebo effect accounted for 88.1%, 55.2%, and 61.3% of the observed unblinded effect size for these end points, respectively. There was no significant difference between unblinded and blinded trials for patient-reported end points (SMD, 0.31; 95% CI, −0.02 to 0.64; P = .07), blood pressure (SMD, 0.26; 95% CI, −0.10 to 0.62; P = .15), all-cause mortality (odds ratio [OR], 0.23; 95% CI, −0.26 to 0.72; P = .36), pain (SMD, 0.03; 95% CI, −0.52 to 0.57; P = .91), or recurrent bleeding events (OR, −0.12; 95% CI, −1.11 to 0.88; P = .88). Conclusions and Relevance The magnitude of the placebo effect found in this systematic review and meta-regression was dependent on the end point. Placebo control in trials of procedural interventions had the greatest impact on exercise-related, quality-of-life, and health care professional–assessed end points. Randomized clinical trials of procedural interventions may consider placebo control accordingly.

Structured Procedures Promote Placebo Effects

Placebo Control and Blinding in Randomized Trials of Procedural Interventions

Preserving the placebo effect after disclosure: A new perspective on non‐deceptive placebos

"I am open to self-belief": A study examining the impact of open-label effects on postexercise affect and postintervention exercise behaviour

["Placebo effect", from personal convictions to collective representations: A psychosocial reading of a pharmacodynamic phenomenon]

Perceived treatment, feedback, and placebo effects in double-blind RCTs: an experimental analysis

Placebo Tests and Matching Estimations on the Effects of Power Structure

Making the Exercise Experience More Pleasant: Effects of Open-Label Placebos on Affective Responses to Exercise Induced through Verbal Suggestions

The powerful placebo effect: fact or fiction?

The Placebo Effect in Exercise and Mental Health Research

Placebo Effects on the Enjoyment of Physical Activity and Performance among Kindergarten Children: A Randomized Controlled Trial

Surgeons and shamans: the placebo value of ritual

Generalization and enhancement of the effects of an active placebo nasal spray on sadness

Enhancing placebo analgesia: Unravelling the powerful interplay of ownership and verbal suggestion

The reward for placebos: mechanisms underpinning placebo-induced effects on motor performance

Placebo stimulates neuroplasticity in depression: implications for clinical practice and research

Effects of sex on placebo effects in chronic pain participants: a cross-sectional study

Placebo Economics: A Systematic Review About the Economic Potential of Utilizing the Placebo Effect

Pain, placebo, and test of treatment efficacy: a narrative review

Double blind: Double talk or are there ways to do better research

Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review